advertisement
Varma R 17
Showing records 1 to 17 | Display all abstracts from Varma R70238 Baseline Fourier-Domain Optical Coherence Tomography Structural Risk Factors for Visual Field Progression in the Advanced Imaging for Glaucoma Study
Zhang X
American Journal of Ophthalmology 2016; 172: 94-103
70272 Steroid-induced ocular hypertension/glaucoma: Focus on pharmacogenomics and implications for precision medicine
Fini ME
Progress in Retinal and Eye Research 2017; 56: 58-83
70238 Baseline Fourier-Domain Optical Coherence Tomography Structural Risk Factors for Visual Field Progression in the Advanced Imaging for Glaucoma Study
Dastiridou A
American Journal of Ophthalmology 2016; 172: 94-103
70272 Steroid-induced ocular hypertension/glaucoma: Focus on pharmacogenomics and implications for precision medicine
Schwartz SG
Progress in Retinal and Eye Research 2017; 56: 58-83
70238 Baseline Fourier-Domain Optical Coherence Tomography Structural Risk Factors for Visual Field Progression in the Advanced Imaging for Glaucoma Study
Francis BA
American Journal of Ophthalmology 2016; 172: 94-103
70272 Steroid-induced ocular hypertension/glaucoma: Focus on pharmacogenomics and implications for precision medicine
Gao X
Progress in Retinal and Eye Research 2017; 56: 58-83
70238 Baseline Fourier-Domain Optical Coherence Tomography Structural Risk Factors for Visual Field Progression in the Advanced Imaging for Glaucoma Study
Tan O
American Journal of Ophthalmology 2016; 172: 94-103
70272 Steroid-induced ocular hypertension/glaucoma: Focus on pharmacogenomics and implications for precision medicine
Jeong S; Patel N
Progress in Retinal and Eye Research 2017; 56: 58-83
70238 Baseline Fourier-Domain Optical Coherence Tomography Structural Risk Factors for Visual Field Progression in the Advanced Imaging for Glaucoma Study
Varma R
American Journal of Ophthalmology 2016; 172: 94-103
70272 Steroid-induced ocular hypertension/glaucoma: Focus on pharmacogenomics and implications for precision medicine
Itakura T
Progress in Retinal and Eye Research 2017; 56: 58-83
70238 Baseline Fourier-Domain Optical Coherence Tomography Structural Risk Factors for Visual Field Progression in the Advanced Imaging for Glaucoma Study
Greenfield DS; Schuman JS
American Journal of Ophthalmology 2016; 172: 94-103
70272 Steroid-induced ocular hypertension/glaucoma: Focus on pharmacogenomics and implications for precision medicine
Price MO; Price FW
Progress in Retinal and Eye Research 2017; 56: 58-83
70238 Baseline Fourier-Domain Optical Coherence Tomography Structural Risk Factors for Visual Field Progression in the Advanced Imaging for Glaucoma Study
Sehi M
American Journal of Ophthalmology 2016; 172: 94-103
70272 Steroid-induced ocular hypertension/glaucoma: Focus on pharmacogenomics and implications for precision medicine
Varma R
Progress in Retinal and Eye Research 2017; 56: 58-83
70238 Baseline Fourier-Domain Optical Coherence Tomography Structural Risk Factors for Visual Field Progression in the Advanced Imaging for Glaucoma Study
Chopra V; Huang D
American Journal of Ophthalmology 2016; 172: 94-103
70272 Steroid-induced ocular hypertension/glaucoma: Focus on pharmacogenomics and implications for precision medicine
Stamer WD
Progress in Retinal and Eye Research 2017; 56: 58-83
70238 Baseline Fourier-Domain Optical Coherence Tomography Structural Risk Factors for Visual Field Progression in the Advanced Imaging for Glaucoma Study
American Journal of Ophthalmology 2016; 172: 94-103
